Increased vasopressin 1A receptor expression in failing human hearts.
about
Arginine vasopressin receptor signaling and functional outcomes in heart failureβ-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.The role of neuropeptides in adverse myocardial remodeling and heart failure.Contrasting acute and chronic effects of tolvaptan on serum osmolality in the EVEREST trial.The Bayh-Dole Act, a lion without claws.Vasopressin Type 1A Receptor Deletion Enhances Cardiac Contractility, β-Adrenergic Receptor Sensitivity and Acute Cardiac Injury-induced Dysfunction.
P2860
Increased vasopressin 1A receptor expression in failing human hearts.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Increased vasopressin 1A receptor expression in failing human hearts.
@ast
Increased vasopressin 1A receptor expression in failing human hearts.
@en
Increased vasopressin 1A receptor expression in failing human hearts.
@nl
type
label
Increased vasopressin 1A receptor expression in failing human hearts.
@ast
Increased vasopressin 1A receptor expression in failing human hearts.
@en
Increased vasopressin 1A receptor expression in failing human hearts.
@nl
prefLabel
Increased vasopressin 1A receptor expression in failing human hearts.
@ast
Increased vasopressin 1A receptor expression in failing human hearts.
@en
Increased vasopressin 1A receptor expression in failing human hearts.
@nl
P2093
P1476
Increased vasopressin 1A receptor expression in failing human hearts.
@en
P2093
Arthur M Feldman
Douglas G Tilley
Emily J Tsai
Valerie D Myers
Weizhong Zhu
P2860
P304
P356
10.1016/J.JACC.2013.09.032
P407
P577
2013-10-16T00:00:00Z